Healthcare provider profile · identity verified

Daniel Lee Magro, M.D.

Family Practice · GERMANTOWN, TN · NPI 1992068563

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	440	143
Atorvastatin Calcium	Atorvastatin Calcium	410	136
Losartan Potassium	Losartan Potassium	290	92
Rosuvastatin Calcium	Rosuvastatin Calcium	220	87
Gabapentin	Gabapentin	178	75
Levothyroxine Sodium	Levothyroxine Sodium	169	52
Alprazolam	Alprazolam	164	43
Metformin Hcl	Metformin Hcl	151	47
Omeprazole	Omeprazole	131	53
Allopurinol	Allopurinol	126	41
Pantoprazole Sodium	Pantoprazole Sodium	119	54
Metoprolol Succinate	Metoprolol Succinate	117	42
Hydrochlorothiazide	Hydrochlorothiazide	115	38
Simvastatin	Simvastatin	112	38
Carvedilol	Carvedilol	110	38
Zolpidem Tartrate	Zolpidem Tartrate	107	25
Lisinopril	Lisinopril	103	38
Tamsulosin Hcl	Tamsulosin Hcl	103	35
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	95	32
Metoprolol Tartrate	Metoprolol Tartrate	94	31
Azithromycin	Azithromycin	89	75
Famotidine	Famotidine	89	38
Escitalopram Oxalate	Escitalopram Oxalate	85	24
Glimepiride	Glimepiride	77	28
Fluticasone Propionate	Fluticasone Propionate	74	31
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	71	32
Pravastatin Sodium	Pravastatin Sodium	71	21
Meloxicam	Meloxicam	69	35
Hydralazine Hcl	Hydralazine Hcl	68	20
Montelukast Sodium	Montelukast Sodium	64	26
Trazodone Hcl	Trazodone Hcl	64	24
Methylprednisolone	Methylprednisolone	62	54
Amoxicillin	Amoxicillin	60	53
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	60	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	28
Potassium Chloride	Potassium Chloride	58	23
Metformin Hcl Er	Metformin Hcl	57	19
Temazepam	Temazepam	56	suppressed
Tramadol Hcl	Tramadol Hcl	52	14
Furosemide	Furosemide	50	23
Clonazepam	Clonazepam	49	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	49	15
Clopidogrel	Clopidogrel Bisulfate	48	17
Albuterol Sulfate Hfa	Albuterol Sulfate	44	25
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	44	12
Azelastine Hcl	Azelastine Hcl	44	29
Sertraline Hcl	Sertraline Hcl	44	16
Mounjaro	Tirzepatide	42	suppressed
Ezetimibe	Ezetimibe	41	16
Atenolol	Atenolol	39	14
Olmesartan Medoxomil	Olmesartan Medoxomil	39	13
Telmisartan	Telmisartan	39	13
Lorazepam	Lorazepam	37	suppressed
Nebivolol Hcl	Nebivolol Hcl	37	14
Valsartan	Valsartan	37	11
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	36	12
Bupropion Xl	Bupropion Hcl	36	12
Clonidine Hcl	Clonidine Hcl	36	15
Ozempic	Semaglutide	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	35	16
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Ramipril	Ramipril	34	suppressed
Meclizine Hcl	Meclizine Hcl	33	17
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	30
Benazepril Hcl	Benazepril Hcl	32	11
Celecoxib	Celecoxib	32	suppressed
Prednisone	Prednisone	32	24
Jardiance	Empagliflozin	31	11
Lansoprazole	Lansoprazole	31	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	30	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	29	suppressed
Colchicine	Colchicine	26	16
Eliquis	Apixaban	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Ibandronate Sodium	Ibandronate Sodium	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	23	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	20
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Fluconazole	Fluconazole	21	16
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	17
Ondansetron Odt	Ondansetron	20	suppressed
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Indapamide	Indapamide	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Cephalexin	Cephalexin	18	14
Diazepam	Diazepam	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Levofloxacin	Levofloxacin	17	16
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Linzess	Linaclotide	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Mupirocin	Mupirocin	15	12
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	11
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Topiramate	Topiramate	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Propranolol Hcl	Propranolol Hcl	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Cefprozil	Cefprozil	11	11
Diclofenac Potassium	Diclofenac Potassium	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error